PT-141
Price range: $74.99 through $712.40
PT-141 10mg is a high-purity, research-grade peptide supplied in a 10mg vial. Commonly used in laboratory research for sexual function studies, neuropeptide signaling, and preclinical experiments.
For laboratory research use only (RUO).
PRODUCT OVERVIEW
PT-141, also known as Bremelanotide, is a synthetic peptide derived from Melanotan-II and is classified as a melanocortin receptor agonist. It has been extensively studied for its interaction with MC3R and MC4R receptors, which are associated with motivation, arousal, and autonomic regulation. PT-141 is notable for its ability to influence central neurological pathways rather than peripheral vascular mechanisms.
KEY FEATURES THAT MAKE SEMAGLUTIDE STAND OUT
- Synthetic melanocortin receptor agonist
- High receptor selectivity for MC3R and MC4R
- Centrally mediated mechanism of action
- Derived from well-characterized peptide frameworks
- Supported by both preclinical and clinical research
In clinical/research use, PT-141 is typically administered as a subcutaneous injection (or intranasal in compounded forms) ~30–60 min before anticipated activity, with dosing and frequency set per protocol.
In clinical/research use, PT-141 is typically administered as a subcutaneous injection (or intranasal in compounded forms) ~30–60 min before anticipated activity, with dosing and frequency set per protocol.
Common Side Effects:
Common transient side effects include nausea, facial flushing, mild headache, and temporary increases in blood pressure, with injection-site reactions also possible.
Who Should Avoid:
PT-141 should be avoided by individuals with uncontrolled hypertension, cardiovascular disease, pregnancy or breastfeeding, and those with known hypersensitivity, as safety is not established in these groups.
Lab Testing / Quality:
Research/clinical grade PT-141 is supplied as high-purity lyophilized peptide (e.g., >98% HPLC) with quality documentation; proper aseptic technique is required for reconstitution and study use.
Storage:
Store the lyophilized peptide refrigerated (2–8 °C) in a dry, dark place; after reconstitution with bacteriostatic water, keep refrigerated and use within the specified stability window per protocol.
1. What is PT-141 ?
PT-141, also known as Bremelanotide, is a synthetic peptide widely studied in laboratory settings for its interaction with melanocortin receptors. The 10mg format is designed for controlled research applications.
2. What is PT-141 commonly researched for?
PT-141 is commonly researched for its role in:
- Melanocortin receptor signaling
- Neurochemical and behavioral pathways
- Central nervous system research models
3. How is PT-141 different from other peptides?
Unlike many peptides that focus on hormonal pathways, PT-141 is studied primarily for its direct action on the central nervous system, rather than peripheral hormone production.
4. How should PT-141 be stored?
PT-141 should be stored in a cool, dry place away from direct light. Proper storage helps maintain peptide stability and research integrity.
5. Is PT-141 safe?
PT-141 (10mg) is intended strictly for laboratory research use only (RUO). It is not approved for human or veterinary use.